Ctrl K
Last 13 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.53 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 3203.39 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0% | — | — | — | — | — | 100.0% | 100.0% | — | 100.0% | — | — | -3459.0% | 100.0% |
| — | — | — | — | — | — | — | — | — | 0.0% | — | — | — | — | |
| Operating Margin | -145459.4% | — | — | — | — | — | -93965.5% | -10568.7% | — | -3608.1% | — | — | -6774.4% | -4331.6% |
| — | — | — | — | — | — | — | — | — | +16.7% | — | — | — | — | |
| Net Margin | -155404.4% | — | — | — | — | — | -95028.7% | -11264.9% | — | -6834.8% | — | — | -7339.4% | -5332.4% |
| — | — | — | — | — | — | — | — | — | -28.2% | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| ROA | -2200.9% | -332.6% | -286.7% | -449.5% | -243.7% | -99.4% | -450.2% | -73.1% | -79.6% | — | -567.9% | -365.1% | -288.1% | -146.4% |
| — | -234.7% | +36.3% | -514.7% | -206.1% | — | +20.7% | +80.0% | +72.4% | — | — | — | — | — | |
| ROIC | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.07 | 0.14 | 0.08 | 0.07 | 0.19 | 0.11 | 0.41 | 0.25 | 0.30 | — | 0.08 | 0.08 | 0.14 | 0.32 |
| — | +25.9% | -79.3% | -71.8% | -37.2% | — | +391.1% | +206.5% | +121.7% | — | — | — | — | — | |
| Quick Ratio | 0.07 | 0.14 | 0.08 | 0.07 | 0.19 | 0.11 | 0.41 | 0.25 | 0.30 | — | 0.08 | 0.08 | 0.14 | 0.32 |
| — | +25.9% | -79.3% | -71.8% | -37.2% | — | +391.1% | +206.5% | +121.7% | — | — | — | — | — | |
| Interest Coverage | -23.81 | -34.97 | -6.51 | -29.76 | -5.92 | -23.37 | -79.04 | -14.81 | — | -1.12 | -3.56 | -2.68 | -11.99 | -4.33 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 13 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NTHI stock.
Neonc Technologies Holdings, Inc.'s current P/E is -1.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Neonc Technologies Holdings, Inc.'s current operating margin is -145459.4%. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Neonc Technologies Holdings, Inc.'s business trajectory between earnings reports.